13F HOLDINGS REPORT
DCVC Opportunity Fund II GP, LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001104659-25-078025
Total Value
$115.3M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Rocket Lab Corp | RKLB | 2,663,139 | $95.3M | 82.65% |
| 2 | Recursion Pharmaceuticals, Inc. | RXRX | 3,951,141 | $20.0M | 17.35% |